Alnylam's stock surges after Blackstone confirms $2 billion investment [MarketWatch]
Alnylam Pharmaceuticals, Inc. (ALNY)
Last alnylam pharmaceuticals, inc. earnings: 2/6 08:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.alnylam.com/investor-overview
Company Research
Source: MarketWatch
Shares of Alnylam Pharmaceuticals Inc. rallied 7.4% in premarket trading Monday, after Blackstone Group Inc. confirmed that it was investing $2 billion in the biopharmaceutical company. The deal was earlier reported by The Wall Street Journal. The investment includes $1 billion to buy 50% of the royalties and commercial milestones of Alnylam's high cholesterol treatment inclisiran, and up to $150 million to develop Alnylam's cardiometabolic programs vutrisiran and ALN-AGT. Blackstone will also provide Alnylam with a term loan of up to $750 million and is buying $100 million worth of newly issued stock. Alnylam's stock has gained 1.5% over the past three months through Friday, while Blackstone shares have lost 15.9% and the S&P 500 has declined 15.2%.
Show less
Read more
Impact Snapshot
Event Time:
ALNY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ALNY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ALNY alerts
High impacting Alnylam Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
ALNY
News
- ProQR Nominates Martin Maier, PhD to Board and Announces Annual Meeting of Shareholders to be Held May 22, 2024 [Yahoo! Finance]Yahoo! Finance
- Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
- Gene Therapy: Non-Viral Vectors [Forbes]Forbes
- Alnylam to Webcast Conference Call Discussing First Quarter 2024 Financial ResultsBusiness Wire
- ALNY ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Alnylam Pharmaceuticals, Inc.Accesswire
ALNY
Earnings
- 2/15/24 - Beat
ALNY
Sec Filings
- 4/1/24 - Form ARS
- 4/1/24 - Form DEFA14A
- 4/1/24 - Form DEF
- ALNY's page on the SEC website